Track Categories

The track category is the heading under which your abstract will be reviewed and later published in the conference printed matters if accepted. During the submission process, you will be asked to select one track category for your abstract.

  • Track 1-1Chromosome banding techniques and staining
  • Track 1-2International System for human Cytogenetic Nomenclature (ISCN)
  • Track 1-3Chromosome abnormalities
  • Track 1-4Tumor Cytogenetics
  • Track 1-5Cancer Cytogenetics
  • Track 1-6Expression profiling, gene targeting, tissue-specific and inducible gene ablation
  • Track 2-1Gene Organisation
  • Track 2-2Isolation of DNA & RNA
  • Track 2-3Nucleic acid hybridisation
  • Track 2-4Gene Cloning
  • Track 2-5Selection, screening, and analysis of recombinants
  • Track 3-1Computational biomodeling
  • Track 3-2Computational neuroscience
  • Track 3-3Computational pharmacology
  • Track 3-4Computational pharmacology
  • Track 3-5Computational Entomology
  • Track 3-6Next generation sequencing
  • Track 4-1Behavioral neurogenetics
  • Track 4-2Cross-species gene conservation
  • Track 4-3Neural development
  • Track 4-4Cognitive genomics
  • Track 4-5Computational Neurogenetic Modeling
  • Track 5-1Gene Polymorphisms in Chronic Periodontitis
  • Track 5-2Genetics and Susceptibility to Periodontists
  • Track 5-3Effect of gene polymorphisms on periodontal diseases
  • Track 5-4Epigenetics in periodontics
  • Track 5-5Periodontitis is a multifactorial disease
  • Track 5-6Inherited periodontitis
  • Track 6-1Histone modification
  • Track 6-2DNA methylation
  • Track 6-3X-inactivation
  • Track 6-4Clinical Epigenetics
  • Track 6-5Translational epigenetics
  • Track 6-6Reproductive epigenetics
  • Track 6-7Environmental Epigenetics
  • Track 7-1Granulocyte Immunology
  • Track 7-2Genes and Immunity
  • Track 7-3Immunogenetics and Pharmacogenetics
  • Track 7-4Vasculitis and Autoimmune Disease
  • Track 7-5Platelet Immunology
  • Track 7-6Genetics of Allo Antigens
  • Track 7-7Genetic control of immune cell activation
  • Track 7-8Chronic Inflammation
  • Track 7-9Immunogenicity
  • Track 8-1Gene Polymorphism
  • Track 8-2Regenerative Medicine
  • Track 8-3Gene Editing and CRISPR Based Technologies
  • Track 8-4Viral Gene Therapy
  • Track 8-5Ethical Issues Related To Gene Therapy
  • Track 8-6Advanced Therapy Production
  • Track 9-1Mapping of the brain and behaviour
  • Track 9-2Cell culture, Network analysis
  • Track 9-3Improvement of appropriate light sources
  • Track 9-4Transfection methods
  • Track 9-5Parkinson disease, Epilepsy
  • Track 9-6Forward cheamogenomics
  • Track 9-7Reverse chaemogenomics
  • Track 9-8Personalized medicine
  • Track 9-9Phenotypic screening
  • Track 10-1Somatic Cell Reprogramming
  • Track 10-2Tissue Regeneration
  • Track 10-3Vascular Regeneration
  • Track 10-4Articular Cartilage Tissue 211 Engineering
  • Track 10-5Oral Bone Reconstruction
  • Track 11-1Gene fusions
  • Track 11-2Eukaryotic Genomes
  • Track 11-3Prokaryotic Genomes
  • Track 11-4Genetic Recombination
  • Track 11-5Genetic Recombination
  • Track 11-6Transposons and Transposition
  • Track 11-7Mechanisms of Gene Transfer
  • Track 12-1Modelling Threading
  • Track 12-2Structure databases
  • Track 12-3Proteomics
  • Track 12-4Traditional structural prediction
  • Track 12-5Traditional structural prediction
  • Track 12-6Structural homology
  • Track 12-7Structural bioinformatics
  • Track 13-1DNA Fingerprinting
  • Track 13-2Evaluation and presentation of DNA evidence
  • Track 13-3Kinship testing
  • Track 13-4Lineage markers
  • Track 13-5Single nucleotide polymorphisms
  • Track 13-6Statistical interpretation of STR profiles
  • Track 13-7PCR amplification
  • Track 13-8Anthropological studies
  • Track 14-1Nutrition Market
  • Track 14-2Clinical Trials
  • Track 14-3Obesity
  • Track 14-4Genetic variations affecting the nutritional environment
  • Track 14-5Dietary bioactives with genome
  • Track 15-1Genetic Testing
  • Track 15-2Digital Genome Market
  • Track 15-3Global genetic disorder diagnosis market
  • Track 15-4Pharmacogenetic testing
  • Track 15-5Inherited disorder testing
  • Track 16-1Tumorigenesis and Cancer Diagnostics
  • Track 16-2Precision Medicine & Clinical Diagnostics
  • Track 16-3Biomarkers in Drug Discovery
  • Track 16-4Exploring, identifying & validating new biomarkers
  • Track 17-1Nanotechnology in Genetics
  • Track 17-2Genes and Chromosomes
  • Track 17-3Genetic Linkage and Chromosome Mapping
  • Track 17-4Regulation of Gene Activity
  • Track 17-5Quantitative Genetics and Multifactorial Inheritance
  • Track 17-6Genetic Engineering and Genome Analysis
  • Track 17-7Principles of Genetic Transmission
  • Track 17-8CRISPR-cas 9 Technology
  • Track 18-1Maternal transmission, heteroplasty
  • Track 18-2Complex Parent of origin effects due to genomic imprinting
  • Track 18-3Autosomal recessive characterized by variable expressivity, and genetic heterogeneity
  • Track 18-4Turner Syndrome
  • Track 18-5Polycystic Kidney Disease
  • Track 18-6Osteogenesis Imperfect
  • Track 18-7Neuromuscular Disorders
  • Track 18-8Autosomal dominant disorders
  • Track 18-9Autosomal Recessive disorders
  • Track 18-10Huntington Disease
  • Track 18-11Holoproencephaly
  • Track 18-12Hemochromatosis
  • Track 20-1The Genetic Basis of Cancer
  • Track 20-2Oncogenes
  • Track 20-3Cancer Genetics in the Clinic
  • Track 20-4Genetic Alternations in Common Cancers
  • Track 20-5Cancer Genomes
  • Track 20-6Genetics of common cancers
  • Track 20-7Pediatric Cancer
  • Track 21-1Human Genome Sequence and Variation
  • Track 21-2From Genes to Genomics to Proteomics
  • Track 21-3Oligogenic Disease
  • Track 21-4Formal Genetics of Humans: Multifactorial Inheritance and Common Diseases
  • Track 21-5Human Genetics of Infectious Diseases
  • Track 21-6Gene Action: Developmental Genetics
  • Track 21-7Consanguinity, Genetic Drift, and Genetic Diseases in Populations with Reduced Numbers of Founders
  • Track 21-8Cloning in Research and Treatment of Human Genetic Disease
  • Track 21-9Genetic disorders in Embryology
  • Track 22-1Germplasm for breeding
  • Track 22-2Molecular breeding
  • Track 22-3Molecular genetic modifications and genome-wide genetics
  • Track 22-4Marketing and societal issues in breeding
  • Track 22-5Plant cellular organization and genetic structure
  • Track 22-6Clonal propagation and in vitro culture
  • Track 22-7Plant genetic resources
  • Track 22-8Pathogenic diseases and variation in plants
  • Track 23-1Role of Histones and their Acetylation in Control of Gene Expression
  • Track 23-2Transgenic Regulation in Laboratory Animals
  • Track 23-3The Polymerase Chain Reaction
  • Track 23-4Non-random mating
  • Track 23-5Natural selection
  • Track 23-6DNA Replication and its Control
  • Track 23-7Molecular Cloning
  • Track 24-1Chromosome disorders
  • Track 24-2MathematicaI and population genetics
  • Track 24-3Patterns of in heritance
  • Track 24-4Drug Metabolism
  • Track 24-5Genetic Variations revealed solely by effects of drugs
  • Track 24-6Pharmacogenetics
  • Track 24-7Genetic factors in common diseases
  • Track 25-1Hardy-Weinberg equilibrium
  • Track 25-2Microevolution
  • Track 25-3New developments
  • Track 25-4Genetic drift, bottlenecks & founder effects
  • Track 25-5Mutation
  • Track 25-6Genetic diversity